Global Ankylosing Spondylitis Treatment Market Research Report 2023

Report ID: 1989322 | Published Date: Jan 2026 | No. of Page: 80 | Base Year: 2025 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ankylosing Spondylitis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Disease-Modifying Anitrheumatic Drugs (DMARDs)
        1.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
        1.2.4 Biologics
    1.3 Market by Application
        1.3.1 Global Ankylosing Spondylitis Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Juveniles
        1.3.3 Adults
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Ankylosing Spondylitis Treatment Market Perspective (2017-2028)
    2.2 Ankylosing Spondylitis Treatment Growth Trends by Region
        2.2.1 Ankylosing Spondylitis Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Ankylosing Spondylitis Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Ankylosing Spondylitis Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Ankylosing Spondylitis Treatment Market Dynamics
        2.3.1 Ankylosing Spondylitis Treatment Industry Trends
        2.3.2 Ankylosing Spondylitis Treatment Market Drivers
        2.3.3 Ankylosing Spondylitis Treatment Market Challenges
        2.3.4 Ankylosing Spondylitis Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Ankylosing Spondylitis Treatment Players by Revenue
        3.1.1 Global Top Ankylosing Spondylitis Treatment Players by Revenue (2017-2022)
        3.1.2 Global Ankylosing Spondylitis Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Ankylosing Spondylitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ankylosing Spondylitis Treatment Revenue
    3.4 Global Ankylosing Spondylitis Treatment Market Concentration Ratio
        3.4.1 Global Ankylosing Spondylitis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Treatment Revenue in 2021
    3.5 Ankylosing Spondylitis Treatment Key Players Head office and Area Served
    3.6 Key Players Ankylosing Spondylitis Treatment Product Solution and Service
    3.7 Date of Enter into Ankylosing Spondylitis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Ankylosing Spondylitis Treatment Breakdown Data by Type
    4.1 Global Ankylosing Spondylitis Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Type (2023-2028)
5 Ankylosing Spondylitis Treatment Breakdown Data by Application
    5.1 Global Ankylosing Spondylitis Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Ankylosing Spondylitis Treatment Market Size (2017-2028)
    6.2 North America Ankylosing Spondylitis Treatment Market Size by Country (2017-2022)
    6.3 North America Ankylosing Spondylitis Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Ankylosing Spondylitis Treatment Market Size (2017-2028)
    7.2 Europe Ankylosing Spondylitis Treatment Market Size by Country (2017-2022)
    7.3 Europe Ankylosing Spondylitis Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Ankylosing Spondylitis Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Ankylosing Spondylitis Treatment Market Size (2017-2028)
    9.2 Latin America Ankylosing Spondylitis Treatment Market Size by Country (2017-2022)
    9.3 Latin America Ankylosing Spondylitis Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Ankylosing Spondylitis Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbvie
        11.1.1 Abbvie Company Detail
        11.1.2 Abbvie Business Overview
        11.1.3 Abbvie Ankylosing Spondylitis Treatment Introduction
        11.1.4 Abbvie Revenue in Ankylosing Spondylitis Treatment Business (2017-2022)
        11.1.5 Abbvie Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Detail
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Ankylosing Spondylitis Treatment Introduction
        11.2.4 Amgen Revenue in Ankylosing Spondylitis Treatment Business (2017-2022)
        11.2.5 Amgen Recent Development
    11.3 Janssen Biotech
        11.3.1 Janssen Biotech Company Detail
        11.3.2 Janssen Biotech Business Overview
        11.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Introduction
        11.3.4 Janssen Biotech Revenue in Ankylosing Spondylitis Treatment Business (2017-2022)
        11.3.5 Janssen Biotech Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Ankylosing Spondylitis Treatment Introduction
        11.4.4 Merck Revenue in Ankylosing Spondylitis Treatment Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 UCB
        11.5.1 UCB Company Detail
        11.5.2 UCB Business Overview
        11.5.3 UCB Ankylosing Spondylitis Treatment Introduction
        11.5.4 UCB Revenue in Ankylosing Spondylitis Treatment Business (2017-2022)
        11.5.5 UCB Recent Development
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Company Detail
        11.6.2 Boehringer Ingelheim Business Overview
        11.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Introduction
        11.6.4 Boehringer Ingelheim Revenue in Ankylosing Spondylitis Treatment Business (2017-2022)
        11.6.5 Boehringer Ingelheim Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Detail
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Introduction
        11.7.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Treatment Business (2017-2022)
        11.7.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Ankylosing Spondylitis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Disease-Modifying Anitrheumatic Drugs (DMARDs)
    Table 3. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    Table 4. Key Players of Biologics
    Table 5. Global Ankylosing Spondylitis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Ankylosing Spondylitis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Ankylosing Spondylitis Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Ankylosing Spondylitis Treatment Market Share by Region (2017-2022)
    Table 9. Global Ankylosing Spondylitis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Ankylosing Spondylitis Treatment Market Share by Region (2023-2028)
    Table 11. Ankylosing Spondylitis Treatment Market Trends
    Table 12. Ankylosing Spondylitis Treatment Market Drivers
    Table 13. Ankylosing Spondylitis Treatment Market Challenges
    Table 14. Ankylosing Spondylitis Treatment Market Restraints
    Table 15. Global Ankylosing Spondylitis Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Ankylosing Spondylitis Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Ankylosing Spondylitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ankylosing Spondylitis Treatment as of 2021)
    Table 18. Ranking of Global Top Ankylosing Spondylitis Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Ankylosing Spondylitis Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Ankylosing Spondylitis Treatment Product Solution and Service
    Table 22. Date of Enter into Ankylosing Spondylitis Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Ankylosing Spondylitis Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Ankylosing Spondylitis Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Ankylosing Spondylitis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Ankylosing Spondylitis Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Ankylosing Spondylitis Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Ankylosing Spondylitis Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Ankylosing Spondylitis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Ankylosing Spondylitis Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Ankylosing Spondylitis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Ankylosing Spondylitis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Ankylosing Spondylitis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Ankylosing Spondylitis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Ankylosing Spondylitis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Ankylosing Spondylitis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Abbvie Company Detail
    Table 43. Abbvie Business Overview
    Table 44. Abbvie Ankylosing Spondylitis Treatment Product
    Table 45. Abbvie Revenue in Ankylosing Spondylitis Treatment Business (2017-2022) & (US$ Million)
    Table 46. Abbvie Recent Development
    Table 47. Amgen Company Detail
    Table 48. Amgen Business Overview
    Table 49. Amgen Ankylosing Spondylitis Treatment Product
    Table 50. Amgen Revenue in Ankylosing Spondylitis Treatment Business (2017-2022) & (US$ Million)
    Table 51. Amgen Recent Development
    Table 52. Janssen Biotech Company Detail
    Table 53. Janssen Biotech Business Overview
    Table 54. Janssen Biotech Ankylosing Spondylitis Treatment Product
    Table 55. Janssen Biotech Revenue in Ankylosing Spondylitis Treatment Business (2017-2022) & (US$ Million)
    Table 56. Janssen Biotech Recent Development
    Table 57. Merck Company Detail
    Table 58. Merck Business Overview
    Table 59. Merck Ankylosing Spondylitis Treatment Product
    Table 60. Merck Revenue in Ankylosing Spondylitis Treatment Business (2017-2022) & (US$ Million)
    Table 61. Merck Recent Development
    Table 62. UCB Company Detail
    Table 63. UCB Business Overview
    Table 64. UCB Ankylosing Spondylitis Treatment Product
    Table 65. UCB Revenue in Ankylosing Spondylitis Treatment Business (2017-2022) & (US$ Million)
    Table 66. UCB Recent Development
    Table 67. Boehringer Ingelheim Company Detail
    Table 68. Boehringer Ingelheim Business Overview
    Table 69. Boehringer Ingelheim Ankylosing Spondylitis Treatment Product
    Table 70. Boehringer Ingelheim Revenue in Ankylosing Spondylitis Treatment Business (2017-2022) & (US$ Million)
    Table 71. Boehringer Ingelheim Recent Development
    Table 72. Johnson & Johnson Company Detail
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Ankylosing Spondylitis Treatment Product
    Table 75. Johnson & Johnson Revenue in Ankylosing Spondylitis Treatment Business (2017-2022) & (US$ Million)
    Table 76. Johnson & Johnson Recent Development
    Table 77. Research Programs/Design for This Report
    Table 78. Key Data Information from Secondary Sources
    Table 79. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ankylosing Spondylitis Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Disease-Modifying Anitrheumatic Drugs (DMARDs) Features
    Figure 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Features
    Figure 4. Biologics Features
    Figure 5. Global Ankylosing Spondylitis Treatment Market Share by Application in 2021 & 2028
    Figure 6. Juveniles Case Studies
    Figure 7. Adults Case Studies
    Figure 8. Ankylosing Spondylitis Treatment Report Years Considered
    Figure 9. Global Ankylosing Spondylitis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Ankylosing Spondylitis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Ankylosing Spondylitis Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Ankylosing Spondylitis Treatment Market Share by Players in 2021
    Figure 13. Global Top Ankylosing Spondylitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ankylosing Spondylitis Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Treatment Revenue in 2021
    Figure 15. North America Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Ankylosing Spondylitis Treatment Market Share by Country (2017-2028)
    Figure 17. United States Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Ankylosing Spondylitis Treatment Market Share by Country (2017-2028)
    Figure 21. Germany Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Ankylosing Spondylitis Treatment Market Share by Region (2017-2028)
    Figure 29. China Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Ankylosing Spondylitis Treatment Market Share by Country (2017-2028)
    Figure 37. Mexico Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Ankylosing Spondylitis Treatment Market Share by Country (2017-2028)
    Figure 41. Turkey Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Ankylosing Spondylitis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbvie Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2017-2022)
    Figure 44. Amgen Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2017-2022)
    Figure 45. Janssen Biotech Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2017-2022)
    Figure 47. UCB Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2017-2022)
    Figure 48. Boehringer Ingelheim Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2017-2022)
    Figure 49. Johnson & Johnson Revenue Growth Rate in Ankylosing Spondylitis Treatment Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
Frequently Asked Questions
Ankylosing Spondylitis Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ankylosing Spondylitis Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ankylosing Spondylitis Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Anthraquinone

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Anti Slip Tiles

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More